| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$30,756,665 |
|
|
|
Indirect Value
|
$5,121,576 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$35,878,242 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIR |
Vir Biotechnology, Inc. |
President and CEOOfficer |
• • – |
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,222,222 |
|
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEOOfficer |
• • – |
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,398,666 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-03-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,960 |
1,466,131 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-03-30 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,960 |
6,855 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-05-22 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,216 |
8,963 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-05-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,216 |
1,316,915 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2010-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
63,165 |
63,165 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,341 |
75,715 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
73,290 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,339 |
85,256 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-11-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,756 |
5,378 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,756 |
40,914 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,767 |
50,681 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
65,791 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,339 |
70,250 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,270 |
50,314 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
64,297 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,189 |
62,150 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,339 |
44,874 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2014-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
29,412 |
1,303,827 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,270 |
29,255 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
43,148 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,599 |
45,547 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,149 |
52,681 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-12 |
4/A |
OE |
$0.00 |
$0 |
D/D |
9,189 |
43,466 |
0 |
- |
|
376 Records found
|
|
Page 1 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
